These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23083030)

  • 1. A case of antipsychotic-induced hyperglycemia in a child with insulin dependent diabetes mellitus.
    Stern AP; Trieu ML
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):403-4. PubMed ID: 23083030
    [No Abstract]   [Full Text] [Related]  

  • 2. Atypical antipsychotics for the treatment of disruptive behavior.
    Lohr WD; Honaker J
    Pediatr Ann; 2013 Feb; 42(2):72-7. PubMed ID: 23379410
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical antipsychotic treatment of disruptive behavior disorders in children and adolescents.
    Findling RL
    J Clin Psychiatry; 2008; 69 Suppl 4():9-14. PubMed ID: 18533763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities.
    Valicenti-McDermott MR; Demb H
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):549-60. PubMed ID: 17069544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations.
    McKinney C; Renk K
    Clin Psychol Rev; 2011 Apr; 31(3):465-71. PubMed ID: 21130552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglycemia in a 7-year-old child treated with aripiprazole.
    Logue DD; Gonzalez N; Heligman SD; McLaughlin JV; Belcher HM
    Am J Psychiatry; 2007 Jan; 164(1):173. PubMed ID: 17202568
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing ADHD and disruptive behaviour disorders with combination psychostimulant and antipsychotic treatment.
    Elbe D; Barr AM; Honer WG; Procyshyn RM
    J Psychiatry Neurosci; 2014 May; 39(3):E32-3. PubMed ID: 24758945
    [No Abstract]   [Full Text] [Related]  

  • 9. Elucidating the role of risperidone in the treatment of disruptive behavior disorders.
    Shatkin JP
    J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):377-8. PubMed ID: 16958563
    [No Abstract]   [Full Text] [Related]  

  • 10. An update on medication management of behavioral disorders in autism.
    Baribeau DA; Anagnostou E
    Curr Psychiatry Rep; 2014 Mar; 16(3):437. PubMed ID: 24488702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
    Ekinci O; Sabuncuoglu O
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of aripiprazole in treatment of adults with attention deficit disorder and restless legs syndrome.
    Kikukawa S
    Int J Neuropsychopharmacol; 2008 May; 11(3):439-40. PubMed ID: 18208634
    [No Abstract]   [Full Text] [Related]  

  • 13. Risperdal and parkinsonian tremor.
    Roberts MD
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):230. PubMed ID: 10087680
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
    Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
    Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.
    Ercan ES; Uysal T; Ercan E; Akyol Ardic U
    Pharmacopsychiatry; 2012 Jan; 45(1):13-9. PubMed ID: 21993869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of symptomatic hyperprolactinemia by aripiprazole.
    Wahl R; Ostroff R
    Am J Psychiatry; 2005 Aug; 162(8):1542-3. PubMed ID: 16055781
    [No Abstract]   [Full Text] [Related]  

  • 17. Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone.
    Suzuki Y; Ono S; Fukui N; Sugai T; Watanabe J; Tsuneyama N; Someya T
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):643-4. PubMed ID: 21044656
    [No Abstract]   [Full Text] [Related]  

  • 18. Risperidone-induced sexual dysfunction in a prepubertal child - a case report.
    Wadoo O; Chalhoub N
    J Psychopharmacol; 2009 Aug; 23(6):727-8. PubMed ID: 18562402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 20. Aripiprazole treatment of risperidone-induced hyperprolactinemia.
    Chen JX; Su YA; Wang SL; Bian QT; Liu YH; Wang N; Yang FD; Haile C; Kosten TR; Zhang XY
    J Clin Psychiatry; 2009 Jul; 70(7):1058-9. PubMed ID: 19653986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.